A narrative review of the health disparities associated with malignant pleural mesothelioma

被引:7
|
作者
Freudenberger, Devon C. [1 ]
Shah, Rachit D. [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Div Cardiothorac Surg, Richmond, VA 23284 USA
关键词
Malignant pleural mesothelioma (MPM); health disparities; SURVIVAL; EPIDEMIOLOGY; DISEASE; TRENDS; CARE;
D O I
10.21037/jtd-20-3516
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Malignant pleural mesothelioma (MPM) is a cancer of the mesothelial lining of the pleura that has traditionally been associated with asbestos exposure in an industrial setting. Asbestos usage has fortunately been banned or phased out in most industrialized countries resulting in its decline in countries such as the United States. Despite this, MPM continues to place significant burden on its affected patients resulting in overall poor prognosis and survival. Questions arise as to what factors, especially what health disparities, contribute to the disease's dismal prognosis. This article will present a narrative review of recent literature that identifies the impact age, sex, race, access to medical centers, and economics have on the diagnosis, treatment, and prognosis of MPM. As will be discussed, research has shown that factors including younger age, female sex, non-white race, private insurance, Medicare, and higher income have been associated with better survival in MPM. Whereas older age, male sex, white race, lack of insurance, and lower income are associated with worse survival. The identification of these and other health disparities related to MPM may allow for future research, clinical guidelines, and policies to be implemented to decrease the burden health disparities create in the diagnosis, treatment, and prognosis of patients with MPM.
引用
收藏
页码:3809 / 3815
页数:7
相关论文
共 50 条
  • [1] A Narrative Review-Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma
    Qureshi, Maryum
    Thapa, Bibhusal
    Muruganandan, Sanjeevan
    HEART LUNG AND CIRCULATION, 2023, 32 (05): : 587 - 595
  • [2] Serum diagnostic markers for malignant pleural mesothelioma: a narrative review
    Wang, Jing-Jing
    Yan, Li
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (12) : 4434 - 4440
  • [3] Epidemiology, diagnosis and treatment of the malignant pleural mesothelioma, a narrative review of literature
    Schumann, Sven Oliver
    Kocher, Gregor
    Minervini, Fabrizio
    JOURNAL OF THORACIC DISEASE, 2021, 13 (04) : 2510 - 2523
  • [4] Role of radiation treatment in multimodality treatment of malignant pleural mesothelioma: a narrative review
    Saldanha, Gillian
    Kumar, Sameera
    AME SURGICAL JOURNAL, 2021, 1
  • [5] RADIATION ASSOCIATED MALIGNANT PLEURAL MESOTHELIOMA
    LERMAN, Y
    LEARMAN, Y
    SCHACHTER, P
    HERCEG, E
    LIEBERMAN, Y
    YELLIN, A
    THORAX, 1991, 46 (06) : 463 - 464
  • [6] Malignant Pleural Mesothelioma: A Comprehensive Review
    Jain, Molly
    Crites, Morgan Kay
    Rich, Patricia
    Bajantri, Bharat
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [7] Malignant pleural mesothelioma: a problematic review
    Moskal, TL
    Urschel, JD
    Anderson, TM
    Antkowiak, JG
    Takita, H
    SURGICAL ONCOLOGY-OXFORD, 1998, 7 (1-2): : 5 - 12
  • [8] Chemotherapy in malignant pleural mesothelioma: A review
    Ong, ST
    Vogelzang, NJ
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 1007 - 1017
  • [9] Disparities in Compliance With National Guidelines for the Treatment of Malignant Pleural Mesothelioma
    Espinoza-Mercado, Fernando
    Borgella, Jerald D.
    Berz, David
    Alban, Rodrigo F.
    Sarkissian, Ariella
    Imai, Taryne A.
    Soukiasian, Harmik J.
    ANNALS OF THORACIC SURGERY, 2019, 108 (03): : 889 - 896
  • [10] Malignant pleural mesothelioma associated with recurrent pneumothorax
    Gumber, Leher
    Lim, Cheng Hong
    Naseer, Muhammad Hashim
    Wallace, Helen
    Taylor, Leah
    Parker, Sean
    Cooper, David
    Jackson, Karl
    Thekkudan, Joe
    Keng, Ang
    Aujayeb, Avinash
    BREATHE, 2025, 21 (01)